The microbiota of dogs being treated for congenital porto-systemic shunt

Published in the journal Frontiers in Veterinary Science is a prospective U.S. cohort study, which is the first work to quantify the index of dysbiosis in these cases.

Published on
, bySilvano Marini

Published in the journal Frontiers in Veterinary Science a U.S. study prospective cohort study, which is the first work to quantify the index of dysbiosis in these cases.

In the dog, the most common cause of hepatic encephalopathy can be traced to the presence of a congenital porto-systemic shunt, that is, anabnormality present from birth in which one or more vessels convey blood flow from the intestine directly into the systemic circulation without passing through the filter represented by the liver parenchyma. Whenever possible, with the intent to promote portal blood flow and improve liver function, surgery is the treatment of choice. In terms of medical therapy, the approach aims to reduce enteric toxin production and absorption and involves the use of a low-protein diet and the administration of lactulose, antibiotics, anticonvulsants, and probiotics.

It should be pointed out that, in humans, the link between the gut microbiota, chronic hepatopathy, and hepatic encephalopathy has been the focus of numerous studies that have pointed to theprimary role played by ammonia produced by amino acid degradation and revealed significant differences in the composition of the gut microflora that could fuel symptoms, for example, by altering barrier function or through an increase in urease-producing bacteria. So much so that we speculate that manipulation of the gut microbiota may improve the management of these patients.

For the dog, the data are still to be considered “in progress,” but all indications are that medical treatment of porto-systemic shunts-usually long-term-may interfere with the composition of the microbiota, leading to protracted dysbiosis, with all that this implies on the animal’s condition. Testing this hypothesis was a U.S. prospective cohort study , published in the journalFrontiers in Veterinary Science.

Dysbiosis is as frequent as it is significant

The U.S. work involved 27 dogs (mean age 10 months, mean weight 4.9 kg): all were on hypoprotein diet and lactulose, 22 on antibiotics, 7 on acid-suppressants, 3 on anticonvulsants, 2 on probiotics; 22 had undergone surgical attenuation of porto-systemic shunts. Dysbiosis index and microbiota arrangement were assessed by real-time qPCR. The evaluation showed that 63 percent had a dysbiosis index > 2 – the cutoff for being able to talk about dysbiosis in dogs – with the overall mean being 3.02 (range 4.23-8.42), but in the antibiotic-treated animals it was 4.3 (range -4.23-8.42) versus a mean of 1.52 (range -1.62-5.43) in those without antibiotics(p = 0.58).

The future goal is to optimize the approach

The U.S. one is the first study to quantify the index of dysbiosis in a cohort of dogs diagnosed with congenital porto-systemic shunt and attests that dysbiosis appears definitely frequent and significant, despite not appearing to influence clinical symptomatology. As the authors point out, however, this is a pilot study that should open up for further investigation that can more thoroughly characterize the microbiota of these animals and identify in detail the role of various treatments, including surgery, on microflora alterations. Indeed, the results of futuristic prospective, controlled studies could provide valuable insights into optimizing the approach to the problem.

Reference

Squire N, Lux C, Tolbert K, Lidbury J, Sun X, Suchodolski JS. Characterization of the Fecal Microbiome in Dogs Receiving Medical Management for Congenital Portosystemic Shunts. Front Vet Sci. 2022;9:897760. Published 2022 Jul 28. doi:10.3389/fvets.2022.897760

Explore the latest content
04_03_2025_Digeribilità ed effetti sul microbiota di alimenti crudi congelati, liofilizzati, freschi ed estrusi
Digestibility and effects on the microbiota of frozen, freeze-dried, fresh, and extruded raw foods
27_02_2025_Alterazione del microbioma e del metaboloma in cani ansiosi
Alteration of the microbiome and metabolome in anxious dogs
25_02_2025_Efficacia e tollerabilità dell'olio di canapa nei cani che soffrono di dolore cronico
Efficacy and tolerability of hemp oil in dogs suffering from chronic pain
See more content on
04_03_2025_Digeribilità ed effetti sul microbiota di alimenti crudi congelati, liofilizzati, freschi ed estrusi
Digestibility and effects on the microbiota of frozen, freeze-dried, fresh, and extruded raw foods
27_02_2025_Alterazione del microbioma e del metaboloma in cani ansiosi
Alteration of the microbiome and metabolome in anxious dogs
12_02_2025_Effetti su cute e intestino di nutraceutici e dieta in cani con dermatite atopica
Skin and gut effects of nutraceuticals and diet in dogs with atopic dermatitis
30_12_2024_Effetti di un simbiotico sul microbiota intestinale di cani da slitta
Effects of a symbiotic on the gut microbiota of sled dogs
23_12_2024_Lactobacillus reuteri NBF 2 DSM 32264 migliora microbiota e parametri fecali dei gatti scottish
Lactobacillus reuteri NBF 2 DSM 32264 improves microbiota and fecal parameters of scottish cats
Lactobacillus reuteri nbf 1 dsm 32203 improves intestinal health of Chihuahua dogs
12_11_2024_Ossido di zinco ed estratto di castagno gli effetti sul microbiota intestinale canino
Zinc oxide and chestnut extract: the effects on canine intestinal microbiota
17_09_2024_Ansia e aggressività nei cani da compagnia quanto “pesa” il microbiota intestinale
Anxiety and aggression in pet dogs: how much does the gut microbiota "weigh"?